Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Verrica Pharmaceuticals Inc. | Director | Common Stock | 700K | $4.54M | $6.49 | Jul 5, 2022 | Direct |
Taysha Gene Therapies, Inc. | Director | Common Stock | 1.1M | $1.66M | $1.51 | May 29, 2024 | Direct |
Taysha Gene Therapies, Inc. | Director | Common Stock | 884K | $1.34M | $1.51 | May 29, 2024 | Indirect |
Taysha Gene Therapies, Inc. | Director | Stock Option (right to buy) | 98.4K | May 29, 2024 | Direct | ||
Acumen Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 25K | Jun 10, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ABOS | Acumen Pharmaceuticals, Inc. | Jun 10, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director |
TSHA | Taysha Gene Therapies, Inc. | May 29, 2024 | 2 | $0 | 4 | May 31, 2024 | Director |
TSHA | Taysha Gene Therapies, Inc. | Aug 16, 2023 | 3 | $700K | 4 | Aug 16, 2023 | Director |
TSHA | Taysha Gene Therapies, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 26, 2023 | Director |
TSHA | Taysha Gene Therapies, Inc. | Jun 22, 2023 | 0 | $0 | 3 | Jun 26, 2023 | Director |
ABOS | Acumen Pharmaceuticals, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 7, 2023 | Director |
VRCA | Verrica Pharmaceuticals Inc. | Jul 5, 2022 | 1 | $500K | 4 | Jul 5, 2022 | Director |
ABOS | Acumen Pharmaceuticals, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
ABOS | Acumen Pharmaceuticals, Inc. | Jul 6, 2021 | 5 | $560K | 4 | Jul 8, 2021 | Director |
ABOS | Acumen Pharmaceuticals, Inc. | Jun 30, 2021 | 0 | $0 | 3/A | Jul 8, 2021 | Director |
ABOS | Acumen Pharmaceuticals, Inc. | Jun 30, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |